SomaLogic (SLGC) announced that Institutional Shareholder Services has recommended that SomaLogic stockholders vote “FOR” the pending merger with Standard BioTools (LAB) at the company’s Special Meeting of Stockholders to be held on January 4, 2024. Commenting on the ISS recommendation, SomaLogic issued the following statement: “SomaLogic is pleased that ISS shares its belief that the merger with Standard BioTools is in the best interests of all SomaLogic stockholders and supports the Board’s recommendation that stockholders vote ‘FOR’ the transaction. The transaction with Standard BioTools delivers compelling long-term stockholder value, and SomaLogic urges all SomaLogic stockholders to follow the ISS recommendation by voting “FOR” the value maximizing transaction on the SomaLogic proxy card.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SLGC:
- ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
- SomaLogic urges stockholders to vote for Standard BioTools merger
- SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
- Madryn issues letter to holders correcting SomaLogic statements in presentation
- Skye Fund III issues letter regarding opposition of SomaLogic’s proposed merger